⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABVX News
Abivax SA American Depositary Shares
Abivax to Present Data on Obefazimod at Digestive Disease Week®
globenewswire.com
ABVX
Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment
globenewswire.com
ABVX
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
globenewswire.com
ABVX
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
globenewswire.com
ABVX
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
ABVX
Truffle Capital Unveils the First Edition of the Truffle MedTech 10
businesswire.com
PLSE
AVR
MBOT
ABVX
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
globenewswire.com
ABVX
Abivax Provides 2026 Corporate Outlook
globenewswire.com
ABVX
Abivax to be Added to Nasdaq Biotechnology Index
globenewswire.com
ABVX
Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight
prnewswire.com
ABBV
JNJ
LLY
MRK
PFE
ABVX